Analgesic Solutions
Analgesic Solutions, a subsidiary brand of WCG Clinical, provides clinical trial endpoint optimization services for pharmaceutical sponsors and CROs, including placebo response reduction training, symptom reporting programs, real-time trial analytics, and eCOA/ePRO platforms across eight therapeutic areas.
- Company typePrivate
- Founded2006
- HeadquartersWayland, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Analgesic Solutions does
Analgesic Solutions is a privately held clinical research services firm founded in 2006 and headquartered in Wayland, Massachusetts. Operating as a subsidiary brand under WCG Clinical, the company specializes in clinical trial endpoint assessment and trial optimization services for pharmaceutical sponsors and contract research organizations (CROs). It serves customers across eight therapeutic areas, including CNS/pain, cardiovascular, metabolic, hematology/oncology, infectious disease, dermatology, immunology, and gastroenterology. The company addresses well-documented pain points in clinical trials: high placebo response rates, inconsistent patient symptom reporting, and limited real-time visibility into blinded trial performance.
The company's product portfolio comprises four integrated offerings: (1) Placebo Response Reduction Training, a psychoeducational program that trains monitors, staff, and subjects to maintain neutral expectations and reduce measurement error; (2) Accurate Symptom Reporting, a patient training program built from the company's heritage in pain measurement that reduces variability and improves assay sensitivity; (3) Study Insight Analytics, a real-time monitoring platform that identifies statistically significant aberrant signals during blinded trials; and (4) an eCOA/ePRO platform for electronic clinical outcome and patient-reported outcome data collection. Together, these offerings target measurable improvements in trial data quality, endpoint accuracy, and trial efficiency.
Analgesic Solutions operates on a sales-led, consultative go-to-market motion with quote-based pricing. Revenue is generated through professional services engagements, software platform licensing for the eCOA/ePRO and Study Insight Analytics products, and training program fees. The company's digital presence has been consolidated into the parent WCG Clinical website (wcgclinical.com), giving it access to WCG's enterprise sales force, content marketing infrastructure, and industry events such as the MAGI@home 2026 conference. Distribution is global through direct enterprise sales engagement with pharmaceutical sponsors and CROs.
Analgesic Solutions firmographics
Firmographics- Name
- Analgesic Solutions
- Legal name
- Analgesic Solutions
- Website
- https://analgesicsolutions.com
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Analgesic Solutions, a subsidiary brand of WCG Clinical, provides clinical trial endpoint optimization services for pharmaceutical sponsors and CROs, including placebo response reduction training, symptom reporting programs, real-time trial analytics, and eCOA/ePRO platforms across eight therapeutic areas.
- Ownership category
- akta.pro rank
Analgesic Solutions industry classification
Industry- Product category
- Clinical Trial Endpoint Services
- NAICS
- Custom Computer Programming Services (541511)
- SIC
- Services-Management Consulting Services (8742), Services-Computer Programming, Data Processing, Etc. (7370), Services-Health Services (8000)
- akta.pro primary industry
- Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF)
Keywords
Where Analgesic Solutions is headquartered
LocationHeadquarters
- HQ city
- Wayland
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Analgesic Solutions business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Clinical Trial Solutions Services: Provides specialized clinical trial endpoint assessment and optimization services to pharmaceutical sponsors and CROs. Revenue is generated through professional services engagements, software platform licensing (eCOA/ePRO, Study Insight Analytics), and training programs.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Analgesic Solutions product offering
Product offeringCore offering
Analgesic Solutions provides specialized clinical trial endpoint assessment and optimization services to pharmaceutical sponsors and CROs. Its offerings include placebo response reduction training, accurate symptom reporting programs, real-time study insight analytics, and an eCOA/ePRO platform designed to improve data quality, reduce measurement error, and enhance assay sensitivity in clinical trials. The company operates as a WCG Clinical brand focused on the analgesic and pain therapy therapeutic area.
Product overview
Analgesic Solutions offers a suite of clinical trial solutions focused on endpoint assessment and pain measurement. As part of WCG Clinical's integrated platform, the core offerings include Placebo Response Reduction Training, Accurate Symptom Reporting, Study Insight Analytics, and the eCOA/ePRO Platform. These solutions work together to reduce placebo response, improve data quality, and enhance assay sensitivity in clinical trials. The company operates as a WCG Clinical brand, consolidated into wcgclinical.com alongside WCG's broader portfolio of clinical research solutions including IRB review, site enablement, and data management tools.
Differentiator
Problem solved
Functional benefit
Products and services
- Placebo Response Reduction Training
Quantifiable outcome
- Reduces measurement error and improves assay sensitivity through placebo response reduction training
- +1 more outcomes
Companies that use Analgesic Solutions
Customer profileSegments3 records
Ideal customer profiles2 records
Analgesic Solutions technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Analgesic Solutions partnerships and signals
Strategic signalScale indicators2 records
Recent moves5 records
Expansion highlights4 records
Analgesic Solutions competitors and assessment
Company assessmentBroad incumbents
- Medidata Solutions (Dassault Systèmes): Medidata, a Dassault Systèmes brand, is a broad incumbent in clinical trial technology including eCOA/ePRO (Medidata Patient Cloud), RTSM, and analytics. It overlaps with Analgesic Solutions' technology stack but operates at much larger scale across all trial phases and therapeutic areas.
- IQVIA: IQVIA is the world's largest CRO and offers broad clinical trial services including eCOA, real-world evidence, and endpoint analytics. It competes with Analgesic Solutions across the CRO/sponsor customer base but at vastly greater scale and breadth.
- ICON plc: ICON is a major global CRO offering full-service clinical development, including endpoint assessment and eCOA capabilities. It competes broadly with Analgesic Solutions for pharma sponsor budgets but at much larger enterprise scale.
- Calyx (formerly Parexel informatics): Calyx provides eClinical solutions including IRT, EDC, and CTMS that are sometimes adjacent to endpoint assessment workflows. It overlaps with parts of Analgesic Solutions' clinical trial technology stack and serves similar sponsors.
Direct peers
- YPrime: YPrime provides eCOA, IRT, and clinical supply technologies with strong capabilities in pain and CNS trials. It directly competes with Analgesic Solutions' eCOA/ePRO offering and serves overlapping pharmaceutical sponsors.
- MedAvante-ProPhase (now part of WCG): MedAvante-ProPhase, now a sister brand under WCG Clinical alongside Analgesic Solutions, provides centralized ratings and clinical outcome assessment services for CNS trials. The two units share the same parent and overlapping customer base in endpoint assessment for CNS/pain.
- Clinical Ink: Clinical Ink provides eCOA, ePRO, and direct data capture solutions for clinical trials, particularly in CNS and rare disease. It directly competes with Analgesic Solutions' eCOA/ePRO platform for endpoint assessment business.
- Signant Health (formerly Bracket): Signant Health provides eCOA, ePRO, patient engagement, and clinical supply technology for clinical trials. It directly competes with Analgesic Solutions' eCOA/ePRO and Study Insight Analytics offerings in CNS and pain trials.
- Clario (formerly ERT / Bioclinica): Clario is a leading provider of clinical endpoint technology, eCOA/ePRO, cardiac safety, and imaging solutions for clinical trials. It directly overlaps with Analgesic Solutions' eCOA/ePRO platform and endpoint assessment offerings, and serves the same pharmaceutical sponsor and CRO customers.
Emerging players
- Castor: Castor is an emerging clinical trial technology platform offering ePRO, eConsent, and decentralized trial capabilities. It competes at the technology layer with Analgesic Solutions' eCOA/ePRO offering, particularly for smaller and mid-sized sponsors.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Analgesic Solutions financial estimates
Financial estimateRevenue estimate
Valuation estimate
Analgesic Solutions leadership team
Management profileNumber of profiles
Analgesic Solutions funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Analgesic Solutions M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Analgesic Solutions
What does Analgesic Solutions do?
Analgesic Solutions provides specialized clinical trial endpoint assessment and optimization services to pharmaceutical sponsors and CROs. Its offerings include placebo response reduction training, accurate symptom reporting programs, real-time study insight analytics, and an eCOA/ePRO platform designed to improve data quality, reduce measurement error, and enhance assay sensitivity in clinical trials. The company operates as a WCG Clinical brand focused on the analgesic and pain therapy therapeutic area.
Is Analgesic Solutions a public or private company?
Analgesic Solutions is a private company. It is classified as corporate owned and is currently operating.
When was Analgesic Solutions founded?
Analgesic Solutions was founded in 2006. It employs 11 to 50 people.
Where is Analgesic Solutions based?
Analgesic Solutions is headquartered in Wayland, United States, in the North America region.
How does Analgesic Solutions make money?
One revenue line is on record: clinical Trial Solutions Services.
Who are Analgesic Solutions's main competitors?
Broad incumbents on record are Medidata Solutions (Dassault Systèmes), IQVIA, ICON plc and Calyx (formerly Parexel informatics). Direct peers are YPrime, MedAvante-ProPhase (now part of WCG), Clinical Ink, Signant Health (formerly Bracket) and Clario (formerly ERT / Bioclinica). Castor is listed as an emerging player.
Does Analgesic Solutions have an API?
No public API is recorded for Analgesic Solutions.
What industry is Analgesic Solutions in?
Analgesic Solutions's product category is Clinical Trial Endpoint Services. Its primary akta.pro industry code is HLAGAAAF, Clinical Data Management, Biostatistics & Statistical Programming CROs. Its NAICS code is 541511 and its SIC code is 8742.